• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃 pT2(pm)癌淋巴结清扫不足的肿瘤学安全性边界评估。

The assessment of the oncological safety margin of insufficient lymph node dissection in pT2 (pm) gastric cancer.

机构信息

Department of Surgery, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea.

出版信息

Yonsei Med J. 2014 Jan;55(1):61-9. doi: 10.3349/ymj.2014.55.1.61.

DOI:10.3349/ymj.2014.55.1.61
PMID:24339288
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3874921/
Abstract

PURPOSE

To identify the effect of insufficient lymph node dissection (LND) on the survival of patients with pT2 gastric cancer.

MATERIALS AND METHODS

A total of 340 patients (120 patients with insufficient LND and others with D2 LND) who underwent gastrectomy for pT2 gastric cancer between January 2008 and December 2010 were included.

RESULTS

The incidence of preoperatively diagnosed early gastric cancer was higher and there were fewer metastatic lymph nodes (LNs) in the insufficient LND group than the D2 group, but there was no survival difference between two groups (p=0.365). Among the 89 patients with metastatic LNs after D2 LND, 13 patients (14.6%) had metastatic LNs at selected N2 stations (#10, 11, or 12a), but none of these patients were in the pN1 category. One patient had five metastatic LNs at station #11p with no metastatic LNs at any other stations. The number of metastatic LNs was identified as the only risk factor for LN metastasis at selected N2 stations by logistic regression.

CONCLUSION

If a patient has pN0 or pN1 category after insufficient LND for pT2 gastric cancer, the surgery can be regarded as secure. However, for patients with pN2 or pN3 category, more careful examination is required.

摘要

目的

确定淋巴结清扫不足(LND)对 pT2 期胃癌患者生存的影响。

材料与方法

纳入 2008 年 1 月至 2010 年 12 月期间接受胃切除术治疗 pT2 期胃癌的 340 例患者(120 例 LND 不足和 120 例 D2 LND)。

结果

LND 不足组术前诊断为早期胃癌的发生率较高,转移性淋巴结(LNs)较少,但两组间生存无差异(p=0.365)。在 D2 LND 后转移性 LNs 为 89 例的患者中,有 13 例(14.6%)在选择的 N2 站(#10、11 或 12a)有转移性 LNs,但均未达到 pN1 期。有 1 例患者在站#11p 有 5 个转移性 LNs,其他任何站均无转移性 LNs。逻辑回归确定转移性 LNs 数量是选择的 N2 站发生淋巴结转移的唯一危险因素。

结论

如果 pT2 期胃癌 LND 不足后患者为 pN0 或 pN1 期,则手术可以视为安全。但是,对于 pN2 或 pN3 期患者,需要更仔细的检查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b322/3874921/65895e133ffa/ymj-55-61-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b322/3874921/6c59bbeb7132/ymj-55-61-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b322/3874921/d75a88e22daf/ymj-55-61-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b322/3874921/3f46bedd515b/ymj-55-61-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b322/3874921/65895e133ffa/ymj-55-61-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b322/3874921/6c59bbeb7132/ymj-55-61-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b322/3874921/d75a88e22daf/ymj-55-61-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b322/3874921/3f46bedd515b/ymj-55-61-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b322/3874921/65895e133ffa/ymj-55-61-g004.jpg

相似文献

1
The assessment of the oncological safety margin of insufficient lymph node dissection in pT2 (pm) gastric cancer.胃 pT2(pm)癌淋巴结清扫不足的肿瘤学安全性边界评估。
Yonsei Med J. 2014 Jan;55(1):61-9. doi: 10.3349/ymj.2014.55.1.61.
2
Comparative analysis of station-specific lymph node yield in laparoscopic and open distal gastrectomy for early gastric cancer.早期胃癌腹腔镜与开放远端胃切除术中特定部位淋巴结清扫数量的比较分析
Surg Laparosc Endosc Percutan Tech. 2011 Dec;21(6):424-8. doi: 10.1097/SLE.0b013e3182367dee.
3
Comparison of long term survival outcomes between D1+ and D2 lymph node dissection for ≥ pT2 or pN+ gastric carcinoma: A large scale case-control study using propensity score matching.比较 D1+ 和 D2 淋巴结清扫术对≥pT2 或 pN+ 胃癌患者长期生存结局的影响:一项使用倾向评分匹配的大型病例对照研究。
Eur J Surg Oncol. 2020 Jul;46(7):1239-1246. doi: 10.1016/j.ejso.2020.04.013. Epub 2020 Apr 14.
4
Distal gastric cancer and extensive surgery: a new evaluation method based on the study of the status of residual lymph nodes after limited surgery.远端胃癌与广泛手术:基于有限手术后残留淋巴结状态研究的一种新评估方法
Ann Surg Oncol. 2000 Dec;7(10):719-26. doi: 10.1007/s10434-000-0719-0.
5
The Poor Prognosis of Patients with Stage III Gastric Cancer after D2 Dissection Is Mainly due to Lymphatic Metastasis, Especially the Metastasis of No.12a LN: A Nested Case-Control Study.III 期胃癌患者 D2 清扫术后预后不良主要与淋巴结转移相关,尤其是第 12aLN 转移:巢式病例对照研究。
Oncol Res Treat. 2021;44(6):313-321. doi: 10.1159/000512934. Epub 2021 May 4.
6
Comparing the short-term outcomes of laparoscopic distal gastrectomy with D1+ and D2 lymph node dissection for gastric cancer.比较腹腔镜远端胃癌根治术D1+与D2淋巴结清扫的短期疗效。
Asian J Endosc Surg. 2016 May;9(2):116-21. doi: 10.1111/ases.12269. Epub 2016 Jan 25.
7
Survival benefit of "D2-plus" gastrectomy in gastric cancer patients with duodenal invasion.“D2-plus”胃切除术对十二指肠侵犯的胃癌患者的生存获益。
Gastric Cancer. 2018 Mar;21(2):296-302. doi: 10.1007/s10120-017-0733-6. Epub 2017 Jun 5.
8
Retrieved lymph nodes from different anatomic groups in gastric cancer: a proposed optimal number, comparison with other nodal classification strategies and its impact on prognosis.胃癌不同解剖区域淋巴结检出数:最佳数量的建议、与其他淋巴结分类策略的比较及其对预后的影响。
Cancer Commun (Lond). 2019 Sep 13;39(1):49. doi: 10.1186/s40880-019-0394-4.
9
Assessment of Lymph Node Metastasis in Patients With Gastric Cancer to Identify Those Suitable for Middle Segmental Gastrectomy.评估胃癌患者的淋巴结转移情况,以确定适合进行中段胃切除术的患者。
JAMA Netw Open. 2021 Mar 1;4(3):e211840. doi: 10.1001/jamanetworkopen.2021.1840.
10
Laparoscopic total gastrectomy for upper-middle advanced gastric cancer: analysis based on lymph node noncompliance.腹腔镜全胃切除术治疗中上段进展期胃癌:基于淋巴结清扫不足的分析。
Gastric Cancer. 2020 Jan;23(1):184-194. doi: 10.1007/s10120-019-00986-0. Epub 2019 Jul 12.

引用本文的文献

1
Clinical significance of lymphadenectomy in patients with gastric cancer.胃癌患者淋巴结清扫术的临床意义
World J Gastrointest Oncol. 2016 Feb 15;8(2):136-46. doi: 10.4251/wjgo.v8.i2.136.

本文引用的文献

1
Current management and future strategies of gastric cancer.胃癌的当前治疗策略和未来策略。
Yonsei Med J. 2012 Mar;53(2):248-57. doi: 10.3349/ymj.2012.53.2.248.
2
A systematic review and meta-analysis of the utility of EUS for preoperative staging for gastric cancer.EUS 用于胃癌术前分期的效用的系统评价和荟萃分析。
Gastric Cancer. 2012 Sep;15 Suppl 1:S19-26. doi: 10.1007/s10120-011-0115-4. Epub 2012 Jan 12.
3
Long-term outcomes after laparoscopy-assisted gastrectomy for advanced gastric cancer: a large-scale multicenter retrospective study.
腹腔镜辅助胃癌根治术治疗进展期胃癌的长期疗效:一项大规模多中心回顾性研究。
Surg Endosc. 2012 Jun;26(6):1548-53. doi: 10.1007/s00464-011-2065-7. Epub 2011 Dec 15.
4
Diagnosis of the invasion depth of gastric cancer using MDCT with virtual gastroscopy: comparison with staging with endoscopic ultrasound.MDCT 虚拟胃镜检查对胃癌浸润深度的诊断:与内镜超声分期的比较。
AJR Am J Roentgenol. 2011 Oct;197(4):867-75. doi: 10.2214/AJR.10.5872.
5
Japanese classification of gastric carcinoma: 3rd English edition.日本胃癌分类:第3版英文版
Gastric Cancer. 2011 Jun;14(2):101-12. doi: 10.1007/s10120-011-0041-5.
6
Japanese gastric cancer treatment guidelines 2010 (ver. 3).《日本胃癌治疗指南2010(第3版)》
Gastric Cancer. 2011 Jun;14(2):113-23. doi: 10.1007/s10120-011-0042-4.
7
Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma.胃腺癌 D1 与 D2 胃切除术的荟萃分析。
Ann Surg. 2011 May;253(5):900-11. doi: 10.1097/SLA.0b013e318212bff6.
8
Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.胃癌的外科治疗:随机全国性荷兰 D1D2 试验的 15 年随访结果。
Lancet Oncol. 2010 May;11(5):439-49. doi: 10.1016/S1470-2045(10)70070-X. Epub 2010 Apr 19.
9
T2 or greater disease but were diagnosed preoperatively with early gastric cancer.T2期或更严重的疾病,但术前被诊断为早期胃癌。
Hepatogastroenterology. 2008 Nov-Dec;55(88):2282-6.
10
How good is endoscopic ultrasound for TNM staging of gastric cancers? A meta-analysis and systematic review.超声内镜对胃癌TNM分期的准确性如何?一项荟萃分析与系统评价。
World J Gastroenterol. 2008 Jul 7;14(25):4011-9. doi: 10.3748/wjg.14.4011.